Inventiva S.A. (NASDAQ:IVA) shares saw strong trading volume on Monday . 10,100 shares changed hands during mid-day trading, a decline of 52% from the previous session’s volume of 21,046 shares.The stock last traded at $14.00 and had previously closed at $13.80.
The firm has a market capitalization of $519.96 million, a price-to-earnings ratio of -11.91 and a beta of 0.36. The stock has a 50 day moving average of $12.94 and a 200 day moving average of $13.68. The company has a quick ratio of 7.78, a current ratio of 7.81 and a debt-to-equity ratio of 0.10.
Inventiva (NASDAQ:IVA) last posted its quarterly earnings results on Monday, August 2nd. The company reported ($0.28) EPS for the quarter. The company had revenue of $0.27 million during the quarter. Analysts predict that Inventiva S.A. will post -2.06 earnings per share for the current year.
Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH.
Further Reading: What Factors Can Affect Return on Equity?
Receive News & Ratings for Inventiva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inventiva and related companies with MarketBeat.com's FREE daily email newsletter.